MAM
ALNA

Meeder Asset Management’s Allena Pharmaceuticals ALNA Stock Holding History

Meeder Asset Management’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,614
Closed -$7K – 2608
2019
Q4 		$7K Buy
2,614
+168
+7% +$552 ﹤0.01% 1691
2019
Q3 		$10K Buy
2,446
+2,006
+456% +$8.61K ﹤0.01% 1555
2019
Q2 		$2K Buy
440
+246
+127% +$1.34K ﹤0.01% 1904
2019
Q1 		$1K Sell
194
-347
-64% -$2.52K ﹤0.01% 1662
2018
Q4 		$3K Buy
+541
New +$4.66K ﹤0.01% 1538
2018
Q2 		– Sell
-104
Closed -$1K – 1720
2018
Q1 		$1K Buy
+104
New +$869 ﹤0.01% 1504

Other funds holding ALNA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return

Meeder Asset Management's ALNA Position: Q1 2020 in Review

Meeder Asset Management sold out of Allena Pharmaceuticals (ALNA) in Q1 2020, closing a stake of 2,614 shares — an estimated $7K sold.

Meeder Asset Management first reported a position in ALNA in Q1 2018 and held it in 6 quarters. The position peaked at $10K in Q3 2019. 29 funds tracked by Wall St. Rank hold ALNA as of Q1 2020.

  • Meeder Asset Management reported no remaining Allena Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Meeder Asset Management sold 2,614 Allena Pharmaceuticals shares in Q1 2020, an estimated $7K.
  • Meeder Asset Management first reported a position in Allena Pharmaceuticals in Q1 2018 and held it in 6 quarters.
  • Meeder Asset Management's Allena Pharmaceuticals position peaked at $10K in Q3 2019.
  • 29 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q1 2020.

Based on Meeder Asset Management's 13F filing for Q1 2020, filed 15 May 2020.